Facebook Linkedin Mail X Youtube
Facebook Linkedin Mail X Youtube
    7 days popular

    Latest News

    Stroke rates diverge among TAVI and surgery patients at five years in pragmatic trial

    Evoque tricuspid valve replacement system gains Health Canada approval

    First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE

    Vivasure Medical submits premarket approval for PerQseal Elite vascular closure device

    Boston Scientific withdraws TAVI devices from the market

    EuroPCR 2025: Thirty-day results show promise for Lux-Valve Plus TTVR system

    Medtronic’s Endurant stent graft system receives CE mark for updated rupture labelling

    One-year results show positive safety and haemodynamic performance for biopolymer surgical mitral valve

    TRANSFORM II study of sirolimus DCB completes patient enrolment

    Enrolment completed in ATHENS-HF first-in-human study of Adona interatrial atrial shunt

    Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access technology

    Abbott unveils “promising” Esprit BTK post-approval study data

    Atraverse announces clinical evidence validating Hotwire radiofrequency guidewire system

    Ceryx Medical to develop physiologically responsive pacemaker following funding boost

    Prevencio granted patents to protect proprietary coronary artery disease blood test platform

    Aventus thrombectomy system gains FDA clearance for PE treatment

    Study intensifies call for randomised trial in patients with bicuspid aortic stenosis

    Enrolment milestone met in CORCINCH-HF pivotal trial

    Boston Scientific to acquire IVL developer Bolt Medical

    First patient enrolled in BIOMAG-II trial of Freesolve resorbable scaffold

    MedHub-AI and Terumo partner to distribute AI-powered FFR system in Japan

    EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days

    Biopolymer surgical mitral valve sees favourable results at 30 days

    Innovation and excellence celebrated at second Global Cardiovascular Awards

    Abbott to begin TECTONIC trial of IVL therapy prior to coronary stenting

    No sex difference seen in outcomes for transcatheter tricuspid valve intervention

    Cadrenal Therapeutics and Abbott to collaborate on TECH-LVAD trial

    CRT 2025: AGENT IDE trial results “consistent” out to two years using DCB in ISR

    Initial shortlist for Global Cardiovascular Awards revealed

    Caranx Medical makes US FDA submission for AI TAVI guidance software

    Elixir Medical launches LithiX Hertz Contact IVL system in Europe

    ACC.25: Low-dose colchicine seen to reduce coronary plaque progression in EKSTROM trial

    US FDA approve SSO2 Therapy for the management of myocardial infarction

    Biotronik’s Freesolve resorbable magnesium scaffold gains CE mark

    Humacyte files for investigational use of tissue engineered vessel in CABG

    First-in-human results for dual-drug therapy DCB released

    First cases performed with AtriClip PRO-Mini LAA exclusion system

    EuroPCR 2025: Myval shows promise in latest comparative studies against contemporary TAVI platforms

    First patient enrolled in EASE HF2 study of Intershunt technology for HFrEF treatment

    Past, present and future of cardiovascular innovation celebrated at Global Cardiovascular Awards

    Trial of DCB and scaffold technologies enrols first CTO-PCI patients

    FFR-guided PCI catches up to CABG at five years in FAME 3 study

    TCT 2024 hears one-year results of TRAVEL II study of transcatheter tricuspid replacement system

    TherOx' SSO2

    US FDA accepts PMA application for TherOx’ SSO2

    EuroPCR 2024: NOTION-2 one-year results prompt questions over TAVI in young, low-risk patients with bicuspid aortic valves

    Inquis Medical’s Aventus thrombectomy system found safe and effective for patients with PE

    Renal denervation gains class IIb recommendation in ESC guidelines

    UK MHRA awarded £10 million to fast-track patient access to medical products

    Atrioventricular interval modulation therapy granted US FDA breakthrough designation

    Evident Vascular

    Evident Vascular raises Series B financing to advance AI-powered IVUS platform technology

    First-in-human study of Protaryx transseptal puncture technology completed

    “Urgent need” to move away from lead in mitigating cath lab radiation exposure

    AtriCure’s launches EnCompass clamp in Europe

    FastWave Medical announces successful 30-day first-in-human data on Sola IVL technology

    CX 2025: Managing blood pressure with medical therapy may play a role in limiting AAA growth

    SSCORE registry of super saturated oxygen therapy in LAD STEMI patients begins

    FastWave Medical to commence coronary feasibility study of laser IVL system

    ESC 2024: Chronic coronary syndrome guidelines clarify role of revascularisation and strengthen imaging recommendations

    Penumbra’s STORM-PE randomised trial completes enrolment

    Robotic system “brings transcervical aortic valve replacement a step closer”

    Howard Herrmann appointed CMO for structural heart by Affluent Medical

    New medical device reporting requirements come into effect in the UK

    Cardiac Dimensions secures financing to complete EMPOWER trial

    ACC and AHA acute coronary syndrome guidelines stress radial approach

    EMPACT-MI analysis “reassuring” on use of empagliflozin in patients with poor kidney function

    AtriClip LAA device receives expanded indication

    First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024

    Tria polymer mitral valve gains Indian CDSCO approval

    Edwards Lifesciences continues acquisition spree, announcing JenaValve and Endotronix deals

    ESH guidelines represent a “significant milestone” for hypertension management

    SCOREPAD seeks to address “alarmingly high” mortality in CLTI patients with underlying coronary disease

    AHA 2024: Five-year Amulet IDE data show similar outcomes with Amplatzer and Watchman devices

    4C Medical receives over US$8 million financing for transcatheter mitral regurgitation treatment

    SoloPace announces US FDA clearance and first-in-human use of TAVI temporary pacing system

    Funding round allows completion of RESPONDER-HF trial of Corvia atrial shunt

    First patient joins study of SSO2 therapy post-PCI

    CRT 2025: SCAAR analysis shows comparable outcomes between Prevail and other DCBs

    EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis

    Post-TAVI pacemaker implantation linked to long-term increase in mortality rates

    Initial results of Sikelia transcatheter heart valve shared at TCT 2024

    EuroPCR 2025: Search for suitable candidates for cerebral embolic protection continues

    SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide

    More experienced TAVI centres “less likely to use heart team approach”

    Evoque becomes first transcatheter tricuspid system to gain US FDA approval

    Royal Brompton Hospital installs UK’s first Magnetom Cima.X MRI system

    Edwards Lifesciences to acquire TMVR developer Innovalve

    EuroPCR 2025: Sustained reduction in TR seen at two years with Triclip in real-world data

    ACC.21: Digital app should replace stent cards as a patient PCI record

    Adona interatrial shunt used in first human cases

    DurAVR transcatheter heart valve reaches 100 patients

    Trial of super saturated oxygen therapy after PCI begins enrolment

    SirPAD: Primary results confirm safety and efficacy of sirolimus-coated balloon in PAD

    Siemens introduces “integrated” cath lab imaging system, Artis icono biplane

    Drug therapy may slow progression of aortic valve stenosis

    EuroPCR 2025: DynamX coronary bioadaptor “durable” through three years

    Zoll Medical acquires TherOx

    Cordis initiates SELUTION global coronary registry of coronary DCB

    Transverse Medical completes first patient series involving Point-Guard CEP device

    Medtronic launches VitalFlow ECMO system

    ACC.25: Semaglutide improves walk distance for PAD patients with diabetes

    Early analysis of BIOPATTERN trial offers insights on make-up of coronary plaque

    Medtronic commences Prevail Global study as it seeks coronary DCB approvals in USA and Japan

    cardiovascular disease

    Increased air pollution associated with a rise in deaths from cardiovascular disease

    Cytokinetics shares topline results from MAPLE-HCM trial

    TCT 2024 hears early experience with high-definition IVUS system

    Edward Lifesciences’ Sapien M3 transfemoral mitral valve system gains CE mark

    Translumina extends European reach with Lamed acquisition

    ACC.25: Cerebral embolic protection found not to reduce stroke in BHF PROTECT TAVI trial

    EuroPCR 2025 hears early outcomes of Topaz TTVR system

    HFSA 2024: Aficamten shows improvement in clinical markers used to inform HCM care

    Stephan Windecker (left) presents one-year outcomes from the TRISCEND study

    TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation

    US FDA approves weight loss drug Wegovy to prevent cardiovascular events

    AHA 2024: OPTION trial reports positive outcomes for Watchman FLX at three years after AF ablation

    Patient-specific, 3D printed aortic valve model used in preparation for TAVR procedure

    Tria

    Tria valves surpass 200 patient life years

    SCAI 2025: Early TAVI “should be preferred to clinical surveillance in all age groups”

    “A huge loss to the cardiology community”: Tributes paid to Prof David Foley

    NFL stars to get HeartFlow analysis through GAMEFILM registry study

    TCT 2022: Amulet occluder keeps pace with Watchman at three years

    Philips launches new motorised mobile C-arm system

    SCAI names Srihari S Naidu as president

    TCT 2024: New evidence could prompt rethink over use of colchicine following acute MI

    ACC.25: Bentracimab can reverse bleeding complications linked to ticagrelor

    CMS creates new MS-DRG codes and payments for coronary IVL

    ACC.25: Evolut Low Risk trial shows comparable rates of all-cause mortality and stroke with TAVI and surgery at five years

    ZOLL Medical receives FDA IDE approval for ISO Shock study

    Medtronic Canada completes end-to-end remotely-guided TAVI procedure

    J&J completes acquisition of V-Wave

    Global study shows widening disparity in mitral valve disease outcomes

    Philips introduces VeriSight Pro 3D ICE catheter in Europe

    OPN NC “super-high-pressure” coronary balloon launches in USA

    ESC 2024: New evidence suggests fasting not needed before cardiac catheterisation procedures

    ACURATE IDE results put spotlight on impact of valve under-expansion after TAVI

    Transcatheter tricuspid valve replacement “low risk” for complications

    Ringer perfusion balloon catheter gains US FDA approval

    TCT 2024: New analysis shows difference in rates of stroke among US and non-US cohorts of PROTECTED TAVR trial

    CRT 2025: Acurate neo2 shows “reassuring” performance in observational study after stuttering IDE trial

    Prevail DCB gains expanded CE mark indications

    Accuryn monitoring system detects kidney injury in cardiac surgery patients “earlier than standard serum creatine criteria”

    PERIGON trial demonstrates durability of Avalus aortic valve at seven years

    Functional bicuspid aortic valves associated with improved outcomes compared with other morphology types

    Medtronic announces US launch of Avalus Ultra surgical aortic valve

    GE HealthCare launches AltiX AI.i editions of its Mac-Lab, CardioLab and ComboLab systems

    ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling

    First US centres use GE HealthCare’s Flyrcado cardiac PET imaging agent

    EuroPCR 2025: Three-year data available for Freesolve resorbable magnesium scaffold

    Terumo brings Medis QFR 3.0 to US market

    SoniVie announces advancements in its renal denervation programme

    EECP therapy results “promising” for ANOCA patients

    ESC 2024: RESHAPE-HF2 results move conversation forward on effectiveness of TEER in functional MR

    BI-204 shows positive results for prevention of events associated with atherosclerosis

    Machine learning model provides improved cardiac risk predictions compared to “gold-standard” STS scoring

    ACC.25: ECLIPSE study results support routine use of intravascular imaging during PCI of calcified lesions, investigators say

    Onecrea Medical announces successful first-in-human implants of Crea aortic valve

    Virtue trial to compare sirolimus and paclitaxel DCB technologies

    Medtronic TAVI platforms gain CE mark for expanded redo TAVI indication

    First-in-human implants with Luna TMVR system completed

    Shockwave Medical announces US launch of intravascular lithotripsy catheter

    TCT 2024: TRISCEND II reports positive outcomes for tricuspid replacement system

    Teleflex completes acquisition of Biotronik’s Vascular Intervention business

    CX 2024: Paclitaxel device restrictions “did cause harm”

    CardioFlow’s second-generation TAVI system gains CE-MDR certification

    HOST-IDEA sub-analysis uncovers differences in ultrathin stent platforms

    CRT 2025: ATTENUATE trial shows significant radiation reduction in cath lab procedures using protective drape

    Heartflow shares two-year data from FISH&CHIPS study

    STS 2024: Data show shift in the proportion of patients under 60 receiving TAVI instead of SAVR

    Advanced NanoTherapies closes Series A funding round

    SCAI 2025: SAPT after TAVI should be considered “standard of care”

    Teleflex announce acquisition of Biotronik’s Vascular Intervention business

    App launched to cut time to treatment for STEMI patients

    Early feasibility study of Siegel 8Fr TAVI valve launches

    Biotronik nets short DAPT and calcified lesion indications for Orsiro Mission DES

    ACC.25: TEER with Triclip reduces heart failure hospitalisation versus medical therapy among TR patients in TRILUMINATE trial

    The Foundry announces first-in-human procedure in study of Half Moon TMVR device

    TCT 2024: Drug-eluting resorbable scaffold proves cost effective at one year in LIFE-BTK analysis

    First experience of novel transseptal puncture device shared at STS 2025

    Blue Sail Medical and Biosensors International acquire TAVI company NVT

    Global registry charts pandemic’s impact on TAVI volumes

    First phase of BiVACOR early feasibility study completed

    Medtronic launches Onyx Frontier coronary stent following CE mark approval

    Pivotal trial of AltaValve TMVR system commences in USA and Europe

    ENVISION trial of Abbott’s Navitor TAVI valve in low-risk patients enrols first patient

    TCT 2024: TAVI does not shift the dial in heart failure patients with moderate aortic stenosis

    ACC.25: ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation

    Enrolment begins in trial to assess new therapy in patients deemed unsuitable for anticoagulants

    Ian Meredith joins board of directors at Transverse Medical

    LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke

    Haemonetics completes acquisition of OpSens

    First patient randomised in BACKBEAT study of AVIM therapy for uncontrolled hypertension

    First commercial cases using CrossFAST advanced delivery system performed in USA

    Ten-year NOTION trial data provide important insights on long-term TAVI outcomes and valve durability

    TCT 2024: Seven-year registry data confirm use of AI-enabled FFRCT

    Tria

    Study backs biopolymer used in Foldax’s Tria valve

    TriGUARD 3 given CE mark for embolic protection during TAVI

    American Society of Echocardiography releases new guideline on ultrasound-guided vascular access

    Global Cardiovascular Awards – The full list of winners and highly commended entries

    Oxygen therapy reduces infarct size

    Acolyte system for guidewire positioning and placement in CTOs given US FDA breakthrough device status

    Shockwave commences trial of Javelin IVL catheter in complex coronary disease

    CONFIRM-2 registry demonstrates use of AI-enabled quantitative CT for predicting MACE

    TCT 2024: Six-month data reflect safety and efficacy of Lithix HC-IVL system

    TherOx granted FDA IDE Approval to study next-generation supersaturated oxygen therapy for AMI

    Johnson & Johnson acquires Laminar

    GE HealthCare’s Allia IGS Pulse imaging system approved by the US FDA

    Abbott’s Tendyne TMVR system gains US FDA approval

    Study finds adverse outcomes after decreased use of paclitaxel-coated devices

    Lifemotion ECMO system receives CE mark certification

    TCT Connect 2020: CeloNova announces interim data from 14-day DAPT trial

    “Sustained” clinical benefits seen at six months in Altavalve early feasibility study

    ESC 2024: Invasive strategy does not reduce risk of cardiovascular death or non-fatal MI in older NSTEMI patients

    AHA 2024: Spironolactone misses primary endpoints in CLEAR SYNERGY trial

    ACC.25: Rivaroxaban “a viable alternative to warfarin” in STEMI patients with left-ventricular thrombus

    Genesis MedTech announces sale of JC Medical to Edwards Lifesciences

    Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform

    DeepQure advances clinical trials of its HyperQure extravascular renal denervation system

    CPT code for CathWorks’ 3D FFRangio wire free system

    RevoEdge high-pressure coronary cutting balloon gains CE mark

    Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients with multivessel disease

    CABG shows benefit over PCI in patients with diabetes and multivessel disease in Swedish registry study

    STS 2025: Analysis sheds light on impact of surgeon preference in choice of multi- versus single-arterial grafting in CABG

    HeartFlow shares ten-year data from DISCOVER-FLOW study

    Edwards’ Sapien 3 Ultra Resilia valve gets European launch

    Abbott’s Navitor Vision TAVI valve rolled out in UK and Ireland

    New ESC guidelines combine peripheral arterial and aortic diseases for first time, emphasising interconnectivity of whole arterial system

    Medtronic receives US FDA approval of Affera mapping and ablation system and Sphere-9 catheter

    First cases using Laminar LAAX system performed as part of IDE study

    STS 2021: Study identifies significant gender disparities in CABG

    ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban

    First patients enrolled in coronary de novo trial of Selution SLR drug-eluting balloon

    Enrolment completed in ALL-RISE trial of FFRangio coronary physiology assessment

    Edwards’ Sapien 3 lands US FDA approval for the treatment of asymptomatic severe AS

    EuroPCR 2024: SMART trial data offer new insight on TAVI device choice in women

    Latest TRILUMINATE and TRI.Fr data add to growing body of evidence for tricuspid TEER

    THT 2025: MODERATO II study demonstrates improved echo markers of diastolic dysfunction through AVIM therapy

    FAVOR III identifies major risk factors of cardiovascular events after PCI

    Valcare Medical receives US FDA approval to initiate EFS for Amend transseptal system

    TCT 2024: EARLY TAVR shows early intervention may be fruitful in asymptomatic aortic stenosis

    SCAI 2025: Novel leaflet modification technique shows promise in reducing LVOT obstruction in mitral valve replacement

    “Positive outlook” for transcatheter edge-to-edge treatment of mitral regurgitation

    Latest-generation Evolut TAVI system gains US FDA approval

    VDYNE secures funding for studies of tricuspid valve replacement device

    FastWave Medical closes $19 million financing round to advance IVL portfolio

    CRT 2025: New TAV-in-SAV data underline importance of aortic valve sizing at index procedure

    HeartFlow’s FFRCT analysis passes 250,000 patient milestone

    Randomised trial results support pausing anticoagulation prior to TAVI

    ESC 2024: AI virtual voice assistant identifies complications after TAVI

    STS launches risk calculator for ascending aorta and aortic root surgery

    Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients

    Health Canada grants approval for use of Pascal Precision to reduce significant, symptomatic MR

    COVID-19: American Heart Association issue pandemic CPR guidelines

    THT 2025: Reprieve system meets endpoints in FASTR randomised pilot study

    SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation

    STS 2021: Risk of burnout “a growing concern” in cardiothoracic surgery

    LUMA Vision secures US$22 million in financing

    Medtronic’s Prevail DCB to be studied in US IDE trial

    CorFlow completes series B funding round to evaluate therapeutic treatments for MVO using CoFl system

    Eight-year data “encouraging” for aortic valves using Resilia tissue technology

    ESC 2023: Study assesses impact of using Heartflow FFRCT for diagnosing coronary artery disease

    Full IDE dataset from AMDS PRESERVE trial presented at STS 2025

    Proximo Medical to partner with CeloNova Biosciences

    CMS launches review of coverage for renal denervation

    Laplace Interventional closes series C financing round

    Shockwave Medical’s C2+ coronary IVL catheter launched in select markets

    CAPTURE-1 study of EmStop embolic protection system concludes

    Long-term exercise may lead to aortic enlargement and remodelling

    Alain Cribier: 1945–2024

    Medinol’s EluNIR-PERL coronary stent gains US FDA approval

    First patient procedures performed with Abbott’s balloon-expandable TAVI system

    Teleflex announces US FDA clearance for AC3 Range intra-aortic balloon pump

    Global Cardiovascular Awards return in 2025

    Boston Scientific to acquire renal denervation technology developer SoniVie

    First patient enrolled in study of integrated laser atherectomy and IVL catheter

    Latest round of funding secured to boost clinical programmes for Topaz tricuspid valve system

    Machine learning enables “clinically important” characterisation of coronary artery disease

    Women 50% more likely than men to be given incorrect diagnosis following heart attack

    Research shows “direct mechanistic link” between COVID-19 infection and heart attack, stroke

    Canon Medical launches Alphenix / Evolve Edition angiography system in Europe

    Medtronic gains FDA approval for its latest-generation TAVI system

    New arterial hypertension guidelines update recommendations on the use of renal denervation

    Supira Medical to initiate US clinical programme for pVAD system

    Ian Meredith joins board of directors at Avertix Medical

    Bryan Williams joins BHF as research leader

    EACTS 2024: Digital “prehabilitation” programme reduces adverse events after cardiac surgery

    PMcardio STEMI AI ECG tool earns US FDA breakthrough device designation

    First US patients implanted with FIRE1 remote heart failure monitoring system

    First US implant of Lux-Valve Plus transcatheter tricuspid valve performed in Detroit

    Translumina acquires Blue Medical Devices

    Cathy Gates named as ACC’s new CEO

    Cardiac surgery societies endorse ESC coronary revascularisation recommendations

    Biotronik’s Freesolve resorbable scaffold to be studied in long lesions

    STRIKE-PE interim analysis shows benefit for acute PE patients with syncope

    Lancet Commission urges reframing of coronary disease towards atherosclerosis

    SMARTFLOW study to assess diagnostic accuracy of AI-powered angiography image interpretation software

    US FDA accepts post-approval study reports for Impella

    Coronary CT angiography-guided management of stable chest pains shows benefit out to 10 years

    Updates to HyperVue intravascular imaging system approved by US FDA

    HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products

    FLOWer embolic protection device gains CE mark

    Materialise announces FEops acquisition to offer “interactive” planning for structural heart procedures

    THT 2025: eLym system “promising” for treatment of fluid overload in ADHF patients

    “Low commercial sales” prompt Abbott to pull the plug on selling Absorb

    Trilogy valve shows favourable results at two years in aortic regurgitation patients

    Vantis Vascular completes series B financing round

    Venus Medtech announces Cardiovalve acquisition

    MANIFEST-17k registry shows promising safety performance for PFA

    impella in preventing heart failure in stemi patients

    Impella heart pump approved for use in paediatric patients

    MyOme launches coronary artery disease polygenic risk assessment tool

    VenusP-Valve

    VenusP-Valve gains CE mark

    Kaminari Medical closes €3.8 million financing round to advance intravascular imaging system

    Global Cardiovascular Awards – The full list of winners and highly commended entries

    New expert guidelines allow more patients with pre-existing heart conditions to travel by air

    TAVI company Direct Flow Medical closes after failing to secure funding

    Death rates after CABG and other surgeries “similar” regardless of patient-surgeon gender concordance

    Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial

    Tria

    First patients treated in Indian clinical trial of Tria surgical mitral valve

    TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude

    EACTS 2024: Robotic aortic valve replacement shows promise as an alternative to TAVI

    EuroPCR 2023: Robocath launches new robotic PCI platform

    Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched

    iTFlow blood flow analysis software gains US FDA approval

    STS 2024: Large registry study demonstrates superiority of multi-arterial grafting for multivessel revascularisation

    AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery

    TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients

    COVID-19 infection may increase risk of heart attack up to three years later

    SCAI offers guidance on alternate access for TAVI

    Penumbra launches Indigo system CAT RX catheter in Europe to treat acute coronary syndrome

    ShortCut leaflet splitting device gains US FDA market clearance

    Half of patients enrolled in SELUTION DeNovo coronary trial

    CRT 2025: First-in-human cases using robotic-assisted TMVR system performed in Chile

    Cardiothoracic surgeons are “extremely satisfied” with their jobs

    EACTS and STS guidelines recognise aorta “as an organ in its own right”

    Anteris Technologies reports successful deployment of DurAVR in challenging valve-in-valve case

    CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent

    First transseptal TMVR with Saturn valve performed in CASSINI-EU study

    Todd Berg joins NeoChord as CEO

    LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

    EACTS launches grant scheme for heart valve care in underserved regions

    Shockwave Medical to bring IVL to the Chinese market

    Performance of single-piece biomimetic transcatheter heart valve “encouraging”, first-in-man results indicate

    SCAI highlights cath lab radiation and orthopaedic hazards

    Adona Medical secures financing to initiate clinical use of interatrial shunt device

    First-in-human “remote PCI” performed

    First patients enrolled in high-risk PCI study of Supira pVAD

    Boston Scientific among investors in latest financing round for 4C Medical Technologies

    Immediate revascularisation non-inferior to staged procedure in acute coronary syndrome and multivessel disease

    TAVI overtakes surgical aortic valve replacement in the USA

    TCT 2024: Non-invasive ultrasound therapy device shows promise in calcific aortic stenosis

    Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients

    Positive top-line results from phase 3 GLAGOV imaging study of evolocumab

    First US commercial cases performed with ShortCut leaflet modification device

    Preliminary IDE trial results demonstrate efficacy of dedicated device for coronary perforations

    Risk model adds to prediction tools for surgical risk in adult congenital heart disease patients

    First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment

    First two US patients receive Trisol tricuspid valve

    Results of cell therapy trial in patients with heart failure due to low EF published in JACC

    ACC 2023: Intravascular imaging bests angiography guidance in trial of PCI in complex lesions

    New valvular heart disease guidelines recognise expanding role of TAVI

    First patient enrolled in PROTECT IV randomised controlled trial of Impella

    AVENTUS trial of thrombectomy system for PE treatment completes enrolment

    TRIOMPHE

    Endospan announces positive 30-day outcomes from TRIOMPHE IDE study

    AngelMed launches its Guardian device in the USA

    Philips launches Ultrasound Workspace at ACC.22

    Teleflex grows catheter portfolio following US FDA approval

    EuroPCR 2023: Carbon dioxide flushing prior to TAVI may offer protection against brain injury

    Financing secured to develop “personalised” tricuspid repair system

    ultrasound device

    Non-invasive wearable ultrasound sensor shown to provide mobile cardiac imaging

    CoreMedic and InnoRa partner to accelerate development of ChordArt mitral repair system

    Women with idiopathic intracranial hypertension at twice the risk of cardiovascular disease

    US FDA approval for Abiomed’s Breethe OXY-1 system

    Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval

    ESC 2023: Siemens unveils Acuson Origin imaging platform

    First patients treated in pilot study of Half Moon TMVR device

    Long-awaited US FDA update finds data do not support excess mortality risk for paclitaxel-coated devices

    Creavo Medical Technologies receives US FDA 510(k) approval for Vitalscan

    Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI

    Edwards Lifesciences’ Mitris Resilia valve receives CE mark for mitral replacement surgeries

    ALL-RISE study of CathWorks FFRangio system enrols first patient

    NICE issues recommendations on insertion of cerebral protection devices during TAVI

    First US patient implanted with eSVS Mesh graft in new feasibility study

    TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds

    Analysis shows “positive trend” with thinner strut stents in patients with small vessels

    Orchestra BioMed gains FDA nod to begin study of Virtue SAB sirolimus balloon

    Transfemoral TAVI device gains US FDA breakthrough status for aortic regurgitation

    heart attacks

    UK societies call for concerted effort to tackle cardiovascular disease in women

    Young surgeons to benefit from Transatlantic grant scheme

    Watchman FLX Pro gains US FDA approval

    US FDA grants breakthrough designation for Pi-Cardia’s ShortCut leaflet splitting device

    ACC’s ACTION registry to become Chest Pain—MI Registry

    BIOMAG-I two year results confirm safety and efficacy of Biotronik resorbable magnesium scaffold

    Proximo Medical named as commercialisation partner for Elucid Bioimaging

    First European patient treated with Diamondback 360 coronary orbital atherectomy system

    Tria

    Foldax agrees manufacturing agreement with Dolphin Life Science India

    Relief Cardiovascular closes financing round to fund first-in-human study

    Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation

    Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

    MicroPort receives CE mark approval for Firehawk

    FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit

    HeartFlow receives national reimbursement approval in Japan

    PCR Valves: CUTTING-EDGE registry provides first look at long-term data on surgical procedures after transcatheter valve failure

    First myocardial infarction more likely to be fatal in black people

    Lab-grown heart valves capable of growth in recipient, research finds

    Clinical trial to compare PCI and CABG in women and minorities

    STS 2025: Mechanical aortic valves “confer a significant survival advantage” in patients under 60

    TCT Connect 2020: REFLECT II trial assesses TriGuard 3 embolic protection device in TAVI patients

    Abbott launches its largest Navitor Vision valve size in UK

    Tria

    First clinical results for Tria biopolymer valve published

    DeepQure receives IDE approval of extravascular renal denervation system to treat resistant hypertension

    FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement

    stroke risk factors

    ESOC 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women

    AI

    ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation

    Consumer wearables found to have clinical value in assessing treatment for AF and heart failure

    First Topaz tricuspid valve implanted in European pivotal study

    Caranx Medical announces successful robotic TAVI procedure in an animal

    Brightflow SAS raises €16.5M in series A financing round

    PROACT clinical trial results published for On-X mechanical mitral valve

    CX 2023: Statins save lives after aortic repair regardless of dose

    Abiomed announces PROTECT III clinical data for protected PCI with Impella

    VenusP-Valve

    VenusP-Valve gains FDA authorisation for transpacific clinical study

    Patent granted to Valfix Medical for its percutaneous valve and replacement technology

    US FDA approves Cordis’ Mynx Control venous vascular closure device

    Teleflex buys vascular closure company Essential Medical

    Viz.ai launches AI-powered Viz Vascular Suite

    Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI

    TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation

    Cordis announce positive 24-month results from Selution SFA Japan trial

    Fastwave Medical issued fourth utility patent for laser-IVL platform

    BHF PROTECT-TAVI trial poised to answer key questions about use of cerebral embolic protection during TAVI

    ACC partners with Amgen and Veradigm on TRANSFORM: ACS study

    SCAI position statement “aims to pave the way for renal denervation in the management of hypertension”

    Philips’ “mini” 3D TEE transducer granted US FDA approval

    Scott Drake appointed as Cordis CEO

    First patients join pivotal trial of Aortix pump for treatment of acute decompensated heart failure

    PerQseal Elite vascular closure system gains CE mark

    PCR London Valves 2024: New data presented alongside launch of latest-generation Myval device

    ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial

    Cleerly receives US FDA breakthrough designation for CAD staging system

    Evolut PRO TAVI valve gains approval in China

    First patient treated in LeAAPS trial of left atrial appendage occlusion in cardiac surgery patients

    SCAI updates consensus guidelines on cath lab standards

    CRT 2025: Improved haemodynamics seen with supra-annular TAVI system at two years in SMART trial

    Aktiia’s wrist-mounted blood pressure monitor gains CE mark

    EuroPCR 2023: Three-year EBC MAIN results demonstrate need for pragmatism in left main bifurcation stent strategy

    Early use of mechanical support shows benefit for patients with AMI complicated by cardiogenic shock

    ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI

    Sapien 3

    CRT 2024: New data on outcomes with Sapien TAVI platform

    Two-year LIFE-BTK data show sustained benefits of drug-eluting resorbable scaffold for below-the-knee arteries

    First United States treatment with J-Valve TAVI device

    Long-term study indicates no calcification with CardioCel after eight years

    CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial

    AI-powered point-of-care ultrasound system gains US FDA approval

    ESC 2018: First US FDA-approved study shows TAVI is safe for low-risk patients

    HeartBeam accquires LIVMOR assets

    REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical thrombectomy for PE treatment

    SonieVie

    Study of TIVUS renal denervation system for hypertension treatment completes enrolment

    First mitral valve replacement performed using SSi Mantra robotic system

    Randomised trial data supports use of the PleuraFlow system

    TCT 2024: Adjustable valve replacement system wins Shark Tank innovation prize

    Halting methamphetamine abuse can reverse related heart damage

    Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

    BioCardia gets FDA clearance for catheter to guide Helix delivery system

    EACTS 2023: Statin treatment may benefit SAVR patients

    30-day mortality is significantly lower with MitraClip

    Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial

    TIMELY study will assess impact of AI platform on health of MI patients with coronary disease undergoing cardiac rehabilitation

    Medtronic’s Evolut FX+ TAVI system gains CE mark

    Keith Oldroyd to become CMO at Biosensors

    First implant of MonarQ tricuspid valve replacement system performed in Copenhagen

    HighLife to initiate US pivotal study of transseptal mitral valve replacement system

    AVS completes US$36 million Series B financing ahead of IVL US commercial launch

    Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

    HighLife granted US FDA breakthrough designation for TMVR system

    SV Life Sciences and Third Rock Ventures launch medical device company Cibiem

    EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”

    GLACE study to assess ICE imaging during LAA closure

    TCT 2024: Coronary bioadaptor shows clinical benefit in complex PCI sub-groups

    heart attacks

    New research highlights sex disparity in treatment of CABG patients

    CMS grants transitional pass-through payment for Medtronic’s Symplicity Spyral and Recor’s Paradise renal denervation systems

    CMSS

    CMSS “strongly urges action” to ensure all frontline healthcare professionals are protected

    FDA grants breakthrough device designation to Impella ECP

    Study weighs up discordance between bleeding risk calculation tools

    Conavi Medical receives FDA 510(k) clearance for Foresight intracardiac echocardiography system

    BrightHeart gains US FDA clearance for AI ultrasound software for detecting congenital heart defects

    First patients enrolled in JENA-VAD registry

    LivaNova reaches agreement to sell its heart valve business

    Boston Scientific gains US FDA clearance for AVVIGO+ multi-modality guidance system

    Registry data point to a declining rate of complications among primary MR patients

    CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality

    First patients treated with the Impella ECP heart pump

    First US cases performed with Vertex PE system in SPIRARE II pivotal study

    Merit releases Prelude IDeal hydrophilic sheath

    American Academy of Neurology recommends PFO closure for selected stroke patients

    Simona Zannetti returns to Medtronic to lead aortic business

    ESC 2024: Coronary bioadaptor non-inferior to DES at one-year for TLF

    EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction patients

    Stereotaxis seeks to broaden use of its robotic magnetic navigation system into multiple endovascular fields

    CE mark PASCAL clip-based system for transcatheter tricuspid repair

    Heartbeat International foundation and Biotronik open new centre in the Dominican Republic

    ESC 2024

    ESC 2024 Congress live blog

    Surgical ablation during CABG carries survival advantage for patients with preexisting AF

    Siemens highlights C-reactive protein test at ACC09

    Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment

    Novel drug shows promise as a “bridge” therapy for patients undergoing cardiac surgery

    First-in-man implant of “modular” TAVI device performed in Israel

    British Heart Foundation announces strategy for over half a billion pounds of research funding

    Cardiovalve

    Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system

    TCT 2023: Initial phase of TRISCEND II trial of Evoque transcatheter replacement for severe tricuspid regurgitation meets primary endpoints

    First-in-human procedure performed using Impella RP Flex

    New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers

    FastWave Medical announces completion of first procedures in study of novel peripheral IVL system

    heart attack

    New partnership aims to develop platform for treating heart failure

    AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation

    TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER

    Mobile clinical research specialist Hawthorne Effect appoints new CEO

    PCR London Valves 2024: Medtronic shares Evolut cusp overlap and PVL data

    Melody pulmonary heart valve receives FDA approval for valve-in-valve use

    EnligHTN safe and effective for the treatment of resistant hypertension

    SCAI 2025: Stenting “improves long-term survival” for patients undergoing CTO PCI

    Recurrent heart attacks declining, but overall rate remains high

    “Worrisome” rise in cardiovascular disease predicted out to 2060

    US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE

    FDA approve TSP Crosser transseptal access system

    CE mark for XL version of Perceval surgical aortic valve

    FDA approves Promus Element Plus and Promus Premier coronary stent systems

    AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG

    BioCardia submits 510(k) approval for Morph DNA steerable introducer sheath family

    ESC 2020 Congress: No discernible effect on saphenous vein graft patency from adding ticagrelor to aspirin after CABG

    Ancora Heart enrols first patient in the CORCINCH-HF study

    DurAVR heart valve system gets green light from US FDA for early feasibility study

    First patients treated with Duo tricuspid coaptation system in TANDEM II study

    See the full shortlist for the Global Cardiovascular Awards

    heart attack

    Anxiety affects high proportion of patients with an ICD

    TCT 2023: TAVI system for aortic regurgitation shows promise in ALIGN AR trial

    ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients

    Tria

    First-in-human use of Tria biopolymer heart valve completed

    ESC 2023: ADVENT trial shows PFA is non-inferior to thermal ablation for safety and efficacy in paroxysmal AF

    New York Valves hears five-year data from PARTNER trials focused on small annulus patients

    Early valve replacement falls short in EVOLVED trial

    Texas Heart Institute performs first-in-human implantation of BiVACOR total artificial heart

    Vascular Solutions acquires Zerusa Ltd, manufacturer of the Guardian haemostasis valves

    Interim data from PROACT study confirm patients with On-X Plus 1.5 valve may be safely maintained at anticoagulation levels below current recommended guidelines

    Quidel receives CE mark for its TriageTrue high sensitivity troponin I test

    PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent

    First US procedure performed using ShortCut leaflet splitting device

    Nipro to acquire Infraredx

    TCT 2024: PATCH study reports initial positive results for sutureless vascular closure system

    CRT 2022: Four-year LRT data “support TAVI in low-risk patients”

    First patient treated in head to head trial of TAVI embolic protection devices

    PCI improves angina symptoms without medication in ORBITA-2 trial

    TCT Connect 2020: Acurate neo fails to meet non-inferiority compared to Evolut in SCOPE II trial

    Edwards Lifesciences issues an urgent field safety notice for Centera TAVI system

    First German order for Acarix’ CADScore system

    Abbott receives CE mark for Aveir dual chamber leadless pacemaker system

    US FDA approves Flyrcado injection PET radiotracer for diagnosis of coronary artery disease

    ReCor Medical announces consistent reduction of blood pressure in pooled analysis of three clinical trials at AHA 2022

    CONFORM IDE trial reaches enrolment milestone

    First procedures using Edward Lifesciences’ Inspiris Resilia aortic valve take place

    Surmodics launches Preside hydrophilic coatings for neurovascular, coronary and peripheral applications

    First cases completed in SPIRARE I trial with Vertex system

    Edwards launches ThruPort IntraClude intra-aortic occlusion device

    STS 2021: Five-year COMMENCE results favour Resilia tissue aortic valve

    First patient treated with AtriClip FLEX-Mini LAA device

    Italian boy becomes youngest patient bridged to transplant with the SynCardia Total Artificial Heart

    ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients

    ESC appoints Jean-François Riffaud as CEO

    STS updates risk calculators for tricuspid surgery, CABG and SAVR after TAVI

    Gentuity HF-OCT imaging system receives FDA clearance

    xarelto rivaroxaban

    Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

    TCT Connect 2020: NuVera announces results from first-in-human study of ICE catheter

    Akura Medical

    Akura Medical announces successful first-in-human use of its mechanical thrombectomy platform

    Prevencio receives US patent for AI-powered test of obstructive coronary artery disease

    Second Heart Assist announces further high-risk PCI cases using Whisper mechanical circulatory support device

    Joseph Sabik elected STS president

    FDA approves Evolut PRO+

    Medtronic’s Evolut PRO+ TAVI system gains CE mark

    Evolocumab significantly reduces risk of cardiovascular events

    COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus

    MASTER trial shows positive results for the MGuard embolic protection stent

    Three-year data from ASSURED study of Cardioform ASD occluder released

    Use of clinical support platform “reduces risk of kidney injury” from PCI

    Boston Scientific’s Agent DCB gains first US FDA coronary approval

    heart attack

    Trialists call for rethink over use of MACE as a primary endpoint in cardiovascular trials

    GE Healthcare receives FDA indication approval for Visipaque injection for use with coronary CT angiography

    Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

    Shockwave Medical

    Johnson & Johnson completes acquisition of Shockwave Medical

    Syntax Score website: A tool for the best strategy

    FDA approval for Viola clampless proximal anastomosis device

    LivaNova completes initial divestiture of its heart valve business

    Philips announces LumiGuide 3D imaging technology availability in Europe and USA

    ESC hypertension guidelines stipulate conditions for renal denervation use

    US FDA issues first draft guidance for AI-based medical device development

    Xience Sierra approved for use in USA

    Abbott receives CE mark for the next-generation Mitraclip

    Blood potassium monitor under development to benefit patients with chronic renal failure

    STS 2024: STS elects its first female president

    GE Healthcare and Medis Medical collaborate to commercialise QFR technology

    Nyra Medical secures investment for transcatheter mitral valve repair technology

    EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

    SCAI issues advice for cath labs in light of COVID-19 pandemic

    coronary artery bypass

    “Urgent” action needed to improve outcomes in women undergoing coronary artery bypass surgery

    EuroPCR 2024: Leaflet splitting device may offer efficient option for avoiding coronary obstruction during valve-in-valve procedures

    US launch for Abbott’s Ultreon AI-based coronary imaging platform

    Leadership change at TRiCares sees Atricure and Medtronic veteran join as president and CEO

    Atrial fixation TMVR device may have reduced risk of LVOT obstruction

    ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR microcatheter

    50th patent for HeartFlow secured

    First-in-human implant of Triflo heart valve completed

    DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation

    Simpson Interventions announces US FDA regulatory milestones

    ACC.25: Studies evaluate aortic stenosis referral and detection

    First trial of in-heart micro device for left atrial pressure monitoring launched

    NICE recommends use of Brilique (ticagrelor) in patients who have had a heart attack or episode of unstable angina

    True Dilatation Balloon Valvuloplasty Catheter receives CE mark

    Diamondback 360 atherectomy system gains CE mark

    Investors offer backing for developer of transcatheter mitral chord repair technology

    FDA approves world’s first device for treatment of premature babies and newborns with an opening in their hearts

    TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR

    Edwards Lifesciences to strengthen structural heart business after sale of Critical Care group

    New funding to support expansion of clinical programme for Supira Medical pVAD

    Steps needed to include disadvantaged patients in mitral and tricuspid trials

    ESC 2024: TAVI “superior” to surgery in women with severe aortic stenosis

    FDA grants approval to Tryton for side-branch stent

    PCR e-Course 2020: Cangrelor provided inferior inhibitor of platelet aggregation than tirofiban in STEMI patients

    SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

    EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

    AHA and CRF announce collaborative education programme

    Latest statistics show heart failure on the rise

    Edwards Lifesciences to discontinue its self-expanding valve Centera

    complete-revascularisation

    First patient treated in A PRIORI pilot trial of Aortix circulatory support device

    Edwards Lifesciences to collaborate with Bay Labs to use AI software to improve detection of heart disease

    Next generation TriClip gains CE mark approval

    Abiomed introduces third generation Impella CP heart pumps at SCAI 2017

    Brightflow appoints Sophie Humbert as CEO

    Edwards Lifesciences acquires Harpoon Medical

    Harpoon Medical acquired by Edwards

    DSM and SAT enter partnership to develop the first next-generation heart valve

    PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient

    Abbott initiates ABSORB II clinical trial

    Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND

    Trial seeks to demonstrate benefit of ultra-low dose X-ray technology

    Genous stent is a safe and effective option in STEMI patients

    ESC and EACTS conclude review of left main revascularisation guidelines recommendations

    PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective

    MedHub announces investment and pivotal study completion

    ACC 2023: MitraClip meets endpoints at five years in COAPT trial

    heart attack

    First patient treated using A-Flux Reducer interventional system for angina

    First patients enrolled in study of pulmonary artery denervation treatment

    Data and device tweaks herald ‘practice-changing’ future for bioabsorbable scaffolds

    First patient enrolled in RECOVER IV randomised trial of Impella in AMI patients

    Topaz tricuspid valve replacement system used for the first time in a patient with a pacemaker

    CONFORMAL EFS study results presented at CRT 2023

    Funding secured to support clinical study of Elevate heart pump

    Research project to determine how stretching and blood flow impact engineered heart valves

    Transverse Medical restructures board as it seeks to bring cerebral embolic protection system to market

    ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients using empagliflozin

    Swedish registry data point to survival benefit for younger patients undergoing CABG

    Tria

    Enrolment in Indian clinical trial of Tria mitral valve completed

    First patient enrolled in BIOMICS study for CTO-PCI

    New drugs steal the spotlight at the ESC Congress 2009

    Machine learning predicts 10-year risk of death in patients with suspected or known coronary artery disease 

    Early feasibility study of CroíValve’s Duo tricuspid coaptation valve system launches

    Endotronix submits premarket approval application to US FDA for Cordella pulmonary artery sensor

    CX 2025: Bioresorbable scaffold technology has ‘potential to be a new paradigm for femoropopliteal endovascular intervention’

    “Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021

    French registry study finds fewer cardiovascular deaths among mitral regurgitation patients receiving TEER

    PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of cardiac death after PCI

    Overlapping everolimus-eluting stents not associated with poorer outcomes

    Johnson & Johnson to acquire V-Wave

    US FDA announces plans to address medical device shortage risks

    paclitaxel

    Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg

    First 10-year report of TAVI durability indicates a low rate of structural valve deterioration

    Vectorius granted breakthrough designation for V-LAP left atrial pressure sensor

    ResMed launches AirCurve 10 CS PaceWave for central sleep apnoea

    AltaValve granted US FDA breakthrough device designation

    Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system

    CE mark for 2.5mm Fantom Encore bioresorbable scaffold

    PCI procedures drop by 10% in USA since 2010, research suggests

    NICE lowers threshold for statins to prevent cardiovascular events

    Evolut gets CE mark in low-risk patients and new labelling for bicuspid use

    Cardiac Dimensions receives Australian regulatory approval for its Carillon mitral contour system

    New document on transcatheter therapies for mitral regurgitation launched

    ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD

    Medtronic completes acquisition of Twelve

    Pi-Cardia appoints Gary Gratson to lead commercialisation of ShortCut

    Johnson & Johnson to acquire Shockwave Medical

    HFSA 2024: One-year data from PROACTIVE-HF show reduction in heart failure hospitalisation and all-cause mortality

    First patient enrolled in trial of Cysoni temporary pacing technology

    Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX

    European survey highlights lack of uniformity in heart team implementation

    Infraredx to launch TVC Imaging System and TVC Muller Extended Bandwidth NIRS-IVUS Catheter at ACC 2015

    Merit Medical expands SwiftNinja steerable microcatheter offering

    Study highlights disparity in TAVI outcomes based on availability

    Nitinol Devices & Components acquires Interface Catheter Solutions to create Confluent Medical Technologies

    EMPOWER CAD all-female IVL trial completes enrolment

    Japanese and US regulatory approvals granted for BioFreedom stent

    ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation system

    First patient treated in ARISE II study of Gore ascending stent graft

    WVU team performs pioneering combined robotic aortic valve replacement and coronary bypass procedure

    TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3

    Pie Medical Imaging announces launch of CAAS Qardia 2.0 echocardiography software platform

    Results from studies of HeartFlow coronary technologies shared at SCCT conference

    England’s first COVID-19 lockdown led to a significant drop in PCI procedures

    First-in-man procedure follows US FDA breakthrough designation for NyokAssist PVAD system

    Symetis acquires Middle Peak Medical

    FDA clearance for Medtronic NC Euphora coronary balloon

    AI-derived risk score may improve planning of TEER for secondary mitral regurgitation

    Economic analysis supports cost-effectiveness of Guardian monitoring system in high-risk acute coronary syndromes

    BioCardia shares early data from phase III CardiAMP cell therapy trial

    Registry confirms Neovasc Reducer improves cardiovascular parameters in refractory angina patients

    Two-year results of mitral valve repair using ChordArt device published

    FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI

    Enrolment begins in LOVE-DEB study of Selution SLR sirolimus-eluting balloon

    First-in-man implant of MValve Technologies’ transcaheter mitral valve replacement system

    CONFORM pivotal trial of CLAAS system begins enrolment

    AI models have potential in heart team decision-making, but beware blindspots

    Medinbox launches latest proctoring and remote learning platform for cath labs

    TriClip gets positive vote from US FDA advisory panel

    EACTS launches Innovation Hub to boost investment in surgical innovation

    TCT 2023: EVOLUT Low Risk trial shows continued strong performance for self-expanding TAVI platform out to four years

    ACC 2024: ORBITA-COSMIC shows reduction in chest pain in angina patients receiving coronary sinus reducer, but questions still remain

    PCR London Valves 2024: One-year data affirm clinical performance of Sapien 3 Ultra Resilia TAVI system

    Medeon Biodesign’s XPro large bore vascular closure device achieves successful first-in-man studies

    PCR Valves: Eight-year findings of NOTION I trial show comparable rates of mortality and stroke for TAVI and surgical valve replacement

    Study shows Brilinta treatment reduced thrombotic cardiovascular events in patients with a history of heart attack

    Carmat increases capacity with opening of second production facility

    Investigators find small reduction in disabling stroke from embolic protection device use

    RSA-pace study of Cysoni-XT temporary pacing system granted approval

    Meta-analysis supports DAPT de-escalation after PCI

    Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe

    ACC 2024: Use of Impella CP may boost survival in STEMI patients with cardiogenic shock

    Trial results open door to frozen plasma alternative for bleeding management in cardiac surgery

    New literature review highlights that Perceval sutureless aortic valve is safe

    SCAI 2024 hears additional analysis from SMART trial

    Cordis granted CE mark for Railway sheathless access system

    Pre-existing coronary arterial disease linked to higher rate of myocardial infarction in patients receiving MitraClip

    Corvia completes randomisation in REDUCE LAP-HF II trial

    ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

    SCAI 2023: Two-year results “demonstrate strong clinical and haemodynamic outcomes” of Harmony transcatheter valve

    FDA panel votes favourably on safety and efficacy of Paradise renal denervation system

    Study suggests black tea may help maintain cardiovascular function

    Perceval sutureless valve data presented at EACTS 2020

    Ultromics receives FDA clearance for EchoGo Pro

    Robocath completes European study of robot-assisted PCI

    Xenter unveils dual-sensor TAVI guidewire

    Robotic PCI associated with a 20% reduction in radiation exposure

    “The new EACVI will promote and represent all aspects of cardiovascular imaging in Europe”

    Multiphase and early systolic phase CT screening in TMVR superior to end systole analysis at predicting obstruction risk

    First patient treated in Cardiac Dimension’s TITAN II clinical trial

    MedAlliance’s Selution SLR receives coronary de novo IDE approval

    US FDA approval for Essenz heart-lung machine

    TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens

    heart attack

    Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

    EACTS 2023: Registry study finds “significantly increased” all-cause mortality among older patients selected for TAVI versus SAVR

    Low-dose polypill could be used for primary prevention of cardiovascular events

    Affinity Fusion oxygenation system for adult cardiac surgery gets the CE mark

    Puzzle Medical wins 2022 TCT Shark Tank innovation competition

    First two TAVI procedures completed using Venus-Vitae valve in SMART ALIGN trial

    AI

    US FDA approval for AI-powered left ejection fraction detection device

    AVS and Jacobs Institute partner on study of Pulse IVL system

    Terumo and Medis partner on coronary imaging technology

    Pivotal trial of dissolving film oral anticoagulant reaches completion

    Positive outcomes with MitraClip in two real-world studies

    One in 10 deaths after PCI found to be “preventable”, US state-wide analysis suggests

    First patient enrolled in Frontier IV clinical trial of PerQseal large arteriotomy closure technology

    Venus Medtech targets European growth with senior appointment

    TCT 2023: Agent DCB shows superiority to conventional balloon angioplasty for target-lesion failure in US randomised trial

    Smartphone app uses can identify lung congestion in heart failure patients

    Argentina heart attack death rate nearly halved over 15 years

    Bolus version of Aggrastat is now approved in the USA

    Heart Valve Voice marks 10-year milestone

    Claret Medical closes on series C financing of US$14.5m

    PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR or iFR measurements “virtually identical”

    Vesalio

    Vesalio initiates clinical study evaluating enVast thrombectomy system in patients with STEMI

    RapidAI announces US$75 million growth investment led by Vista Credit Partners

    Biotronik launches Micro RX microcatheter to the US market

    Biotronik partners with Egg Medical to bring radiation protection systems to US healthcare workers

    Comparative study reports favourable outcomes for VasoStat haemostasis device

    Azeem Latib joins Supira Medical as medical director

    High-fat diet found to promote atherosclerosis

    ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome

    TCT 2017: Study challenges recommendations on the management of cardiogenic shock

    First patient enrolled in EXPAND TAVR II trial

    STEMI patients “lose years of life” due to care delays during COVID-19 lockdowns

    Keystone Heart announces first case using TriGUARD 3 CEP device

    “Vast majority” of young myocardial infarction patients do not meet criteria for statin therapy prior to event

    Biotronik launches PK Papyrus covered coronary stent in the USA

    Ryan Egeland joins Big Sky Biomedical

    ESC 2022: Risk score predicts mortality for AF patients after TAVI

    BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system

    Ilika and Cirtec Medical partner on manufacture and commercialisation of Stereax solid-state batteries

    PATCH clinical study of PerQseal vascular closure system reaches 100-patient milestone

    Mortality from cardiovascular disease continues to increase globally

    Zip surgical skin closure device associated with less pain for paediatric patients undergoing congenital heart surgery

    CRT 2021: One-year outcomes after TAVI in low-risk bicuspid aortic stenosis patients meet expectations

    LIVE from TCT: Promising results for novel drug-filled stent

    Philips launches latest version of its Azurion imaging platform

    US FDA grants 510(k) clearance for SavvyWire TAVI guidewire

    Nanox receives FDA approval for its latest generation AI platform for coronary disease detection

    Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events in AF patients

    VersaCross RF Transseptal device found to be efficient for TMVR procedures

    IVL

    Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases

    ACC 2024: Self-expanding valve comes out on top at one year in SMART trial comparing TAVI devices in small aortic annuli

    Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to using iFR

    Edwards Life sciences initiative

    Edwards expands its Every Heartbeat Matters initiative

    Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices

    Four patients successfully treated with ACURATE TA and ACURATE TF devices

    CHOP physicians conduct first-in-human implant of MASA polymeric pulmonary valve

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of August 2021

    HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat heart failure”

    Carag completes CE marking for its breakthrough Carag bioresorbable septal occluder

    Penumbra announces enrolment of first patient in study of mechanical power aspiration for thrombus removal in coronary vessels

    Lars Søndergaard joins Abbott’s structural heart business

    Robert Califf to resign as US FDA commissioner

    BioMatrix Flex improves long-term clinical outcomes, LEADERS trial shows

    Philips announces US FDA approval for enhanced LumiGuide guidewire, marks 1,000th patient treated with 3D device guidance technology

    Alleviant Medical secures funding for second pivotal trial of no-implant atrial shunt

    Sotagliflozin “shows new mechanism of action” in reducing heart attack and stroke among diabetics, kidney disease patients

    US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients

    Medtronic launches Penditure left atrial appendage exclusion system in the USA

    Xience Prime and Xience V receive CE mark for treatment of diabetic patients

    St Jude Medical gets the CE mark for its 23mm Portico Transcatheter Aortic Heart Valve

    Medtronic stops sale of its HVAD system

    Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022

    Smart glasses guide remote support for pioneering TAVI procedure

    First patient treated with PerQseal Elite vascular closure system

    Fifty US centres are now using Claret Medical’s Sentinel cerebral protection system

    MAGICAL-ISR study of MagicTouch sirolimus DCB commences

    MicroPort obtains CE mark for PathBuilder

    Realview Imaging gains FDA approval for Holoscope-i system

    Average age and income of US cardiologists on the rise

    smart watch

    Smart watches could predict higher risk of heart failure and arrhythmia

    First-in-man cross-country robotic coronary angioplasty performed in two Chinese centres

    Valcare Medical appoints scientific advisory board to guide development of mitral annuloplasty device

    LifeVest

    Germany registry shows Zoll LifeVest wearable defibrillator to be safe and effective

    RaySafe unveils new real-time dosimeter

    Mavacamten granted Breakthrough Therapy Designation

    Boston Scientific discontinues Lotus Edge TAVI device

    Siemens launches Luminos Impulse fluoroscopy system

    Findings of meta-analysis “move the conversation forward” on left main revascularisation

    CardioCel bio-scaffold launched and sold in Malaysia

    RANGO registry reports long-term safety and efficacy of Angiolite DES

    Virtual ACC: PRECOMBAT finds PCI as good as CABG at 10 years in left main disease

    PCR Valves: MitraClip G4 shows positive results in EXPAND G4 study

    Post-hoc analysis of Tryton side-branch stent trial published

    Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

    Positive NICE recommendation for Xarelto to prevent atherothrombotic events in CAD and PAD patients

    TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve

    Isaac George named co-principal investigator of pivotal trial of Direct Flow Medical’s Transcatheter Heart Valve System

    heart attack

    Clinical study of CADScor system to identify non-obstructive coronary artery disease in chest pain patients gets underway

    AHA 2016: Two thirds of patients experience plaque regression with the PCSK9 inhibitor evolocumab

    ESC 2017: MobiusHD implant shown to reduce resistant hypertension

    SCAI pushes revised standardised language to improve cardiogenic shock care

    Shockwave coronary IVL gains Japanese approval

    Clinical results of Chocolate Heart drug-coated coronary balloon announced by QT Vascular

    Valentin Fuster given WHF Lifetime Achievement Award

    Surgeons claim “world first” robotic artificial heart pump implant

    PCR London Valves 2019: Meril unveils positive data for Myval

    Acurate Prime TAVI system gains CE mark

    Enrolment begins in Impella ECP pivotal trial after US FDA green light

    TCT 2024: One-year data from SIRONA trial show similar results for sirolimus versus paclitaxel DCB

    ESC 2018: Positive one-year results for Interatrial Shunt Device

    “Significant capability” reported for Enabler-C Catheter System for crossing coronary chronic total occlusions

    Early feasibility study of TAVI platform for treatment of aortic regurgitation completes enrolment

    “Excellent early patency rates” for VEST device

    Armetheon to merge with Espero Pharmaceuticals

    Medtronic’s Avalus pericardial valve receives CE mark and FDA approval

    Evolocumab becomes first PCSK9 inhibitor to be approved for use in the USA to prevent myocardial infarction

    Juventas Therapeutics completes phase I clinical trial for JVS-100

    i-cor synchronised cardiac assist preserves left ventricular function compared with continuous-flow ECLS in cardiogenic shock

    India-designed Myval associated with no device-related mortality at one year

    REMEDEE study meets primary endpoint: OrbusNeich’s Combo dual therapy stent is non-inferior to DES

    FDA approves longer lengths of Resolute Integrity

    Caption Health and Ultromics partner to increase availability of heart disease detection and management tools 

    First patient treated in HEAL-IST clinical trial

    Anteris Technologies and v2vmedtech reach concept lock on VClip TEER system

    Piccolo Medical announces distribution agreement with Spectrum Vascular

    Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US market

    Study finds over 2,000 excess cardiovascular deaths in England and Wales during pandemic

    Michael Jaff joins board of directors at HeartBeam

    TEER non-inferior to surgery in MATTERHORN trial but dividing lines remain

    Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies

    AMA issues unique Category III Current Procedural Terminology codes for HeartFlow FFRct

    Japan and the USA see an increase in PCI procedures

    David J Cohen joins CRF as director of clinical and outcomes research

    Interim REVERSE-IT trial results published in NEJM Evidence

    Streamlined TAVI pathway paves the way for same-day discharge “record”

    Radiaction Medical secures Series C2 funding and announces board addition

    Medtronic receives CE mark for Evolut FX TAVI system to treat severe aortic stenosis

    AHA 2023: RCE Technologies wins Health Tech competition

    Caution needed for TAVI in younger, low-risk aortic stenosis patients

    Longest available real-world follow-up data for Tendyne valve support use of device in select patients

    INFINITY-SWEDEHEART trial of DynamX bioadaptor system completes enrolment

    First patient enrolled in global study of heart failure device trial

    TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation

    Sapien 3 receives expanded FDA indication for valve-in-valve procedures

    Medrad Interventional introduces next generation Fetch2 aspiration catheter

    ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy

    St Jude Medical launches its three-dimensional vessel reconstruction technology in Japan

    Rates of stroke and embolism lower with apixaban compared to rivaroxaban

    CardioPrecision moves into US market

    Study finds reasons for hospital-level variations in bleeding post-angioplasty remain unclear

    ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures

    First implant of ChordArt TMVR system completed

    ACC 2024: AEDs used in a small number of cardiac arrest cases, despite proximity

    heart attacks

    ALERT study to use AI to identify underserved patients eligible for TAVI

    EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable scaffold

    EXCEL: EACTS explains its decision-making on left-main guidelines, and AATS calls for all data to be published

    Three-year Orbit I coronary data presented at CRT 2013

    Medtronic names Laura Mauri as new chief scientific, medical and regulatory officer

    Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine

    Johnson & Johnson completes Abiomed acquisition

    ACC 2023: Equivalent recovery times shown between minimally invasive and conventional surgery for mitral valve repair

    Roadmap launched to guide shared decision-making in heart valve disease treatment

    Patients with new-onset atrial fibrillation after TAVI have highest risk of complications

    SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

    PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI

    ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment

    ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes

    Abiomed given green light for RECOVER IV randomised trial

    MedAlliance to be acquired by Cordis

    No difference in outcomes for AF patients undergoing LAAO and TAVI at the same time

    Bivacor gets US FDA nod for early feasibility of its total artificial heart

    Novel Ultraseal device is a feasible option for left atrial appendage closure

    Hormone therapy linked to heart fat and hard arteries

    Cardiologists share COVID-19 insights

    Woman patient

    Women face a higher risk of heart failure after STEMI

    ESH position paper highlights renal denervation as a third option for hypertension management

    London’s Science Museum honours 50 years of heart transplants

    Shockwave’s coronary IVL device gains TPT payment approval

    Drug-eluting balloon revenue to more than double by 2019

    Shockwave Medical completes Neovasc acquisition

    EuroPCR 2023: Bioresorbable scaffolds as effective as drug-eluting metal stents in heart disease patients

    Cyberonics and Sorin provide merger update

    Philips launches IntraSight interventional applications platform

    Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser

    First valve-in-valve procedure performed with DurAVR transcatheter valve

    Polymer-free stents have similar performance profiles, except in diabetes

    FDA Breakthrough Device Designation for fully implantable left ventricular assist system

    Boston Scientific completes acquisition of Atritech

    Study charts “inequities” in growth of TAVI in US hospitals

    Pioneering pig to human heart transplant heralded as a breakthrough

    RELIEF clinical study of PFO closure for migraine relief begins randomisation

    First procedure completed using Laplace tricuspid valve replacement system

    ACC 2024: Interatrial shunt fails to meet primary endpoint in RELIEVE-HF trial

    EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting stents in diabetic patients

    Resolute maintains sustained efficacy and safety in long-term follow-up

    Bayer’s rivaroxaban granted Priority Review by US FDA to prevent secondary cardiovascular events in patients with acute coronary syndrome

    SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation

    MagicTouch IDE-approved for small coronary artery disease study

    ESC 2023: Hot Line trials add weight to case for intravascular imaging during PCI

    Cost-effectiveness and updated efficacy data from Evolut Low Risk trial shared at CRT 2024

    PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

    Fatty fish and marine omega-3 may reduce risk of heart failure

    BBC Newsnight investigation of EXCEL prompts EACTS to reject 2018 European recommendations on left main disease

    CardioKinetix announces results of Chinese trial evaluating Parachute heart failure device

    Experts update consensus on left atrial appendage closure

    First US implants mark start of DurAVR THV early feasibility study

    SCAI publishes expert consensus statement on calcified coronary lesions

    Purchase of HeartWare by Medtronic completed

    US FDA clears Elucid’s PlaqueIQ imaging analysis software

    4Tech appoints Michael Ennen as president and chief executive officer

    ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation

    Vivasure Medical announces launch of the PerQseal large bore closure device

    Jean-Claude Dubacher named chairman and CEO of B Braun Medical

    Perceval S bioprosthetic valve gets the CE mark approval for extended indications

    First patients treated with Laguna Tech’s Alpha and Zeta aortic valves

    TMVI in inoperable patients is feasible but mortality high at one year

    e-HEALING registry shows positive clinical outcomes for OrbusNeich’s Genous Stent

    Onyx One Clear Study

    Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study

    Jian’an Wang named as editor of JACC: Asia

    ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT

    Successful first human implants of the Tendyne Transcatheter Mitral Valve Implant

    SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes

    Sildenafil-coated stent may help prevent blood clots and restenosis

    Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

    PASCAL poised to rival MitraClip for safety and efficacy

    FDA clears Emerge Balloon Dilatation Catheter

    Adept launches Adducted Arm Scoop product for use during image-guided procedures

    Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ

    PROACTIVE-HF pivotal trial of Cordella pulmonary artery sensor meets primary endpoints

    STS 2021: Cardiothoracic surgery suffers due to COVID-19

    Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed

    HRS 2023: BIO-LIBRA study offers insights into device treatment of non-ischaemic cardiomyopathy

    Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

    ESC 2024: “No need” for potassium supplementation after CABG

    US heart societies express concern over using hydroxychloroquine and azithromycin for COVID-19

    Biosensors gains CE mark approval for BioFreedom Ultra stent system

    First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

    SonieVie

    SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology

    Surgeons perform historic second transplant of a genetically modified pig heart into a human

    Early treatment with Helix system improves ejection fraction and symptoms

    ADVANCE study results show high survival rates and improved quality of life for patients using the CoreValve system

    Mild COVID-19 unlikely to lead to lasting heart damage

    VISION study concludes troponin is a benchmark for cardiac surgery risk

    ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis

    Swiss parliament votes to accept US FDA-approved medical devices

    Thousandth patient enrolled in SELUTION DeNovo coronary study

    Winrevair given US FDA approval for the treatment of pulmonary arterial hypertension

    Sunshine Heart to focus on neuromodulation for heart failure

    TCT 2024 live blog

    FDA approves new device to improve symptoms in patients with advanced heart failure

    Philips iFR Coregistration SyncVision

    Philips announces DEFINE GPS study of PCI guided by integrated iFR and X-ray

    123...5Page 1 of 5

    Most read

    Features

    Profiles

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date will@bibamedical.com
    Advertising: Hannah Shiels hannah@bibamedical.com


    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: info@bibamedical.com

    Terms and Conditions | Privacy Policy
    Facebook Linkedin Mail X Youtube